It is hoped that an additional shot will strengthen COVID-19 protection for children aged 5-11 years, as infections are on the rise again.
WASHINGTON – U.S. government advisers said Thursday that children ages 5-11 should receive a booster dose of Pfizer’s COVID-19 vaccine.
If the Centers for Disease Control and Prevention agrees, as expected, it will open a third COVID-19 injection for healthy primary school children – the same as those already recommended for anyone 12 and older.
It is hoped that the protection will be strengthened for children aged 5-11 years who have been vaccinated, as infections are on the rise again.
Earlier this week, the Food and Drug Administration allowed Pfizer’s child-sized amplifier to be offered at least five months after the youth’s last shot.
The CDC is taking the next step in recommending who needs vaccinations. His counselors discussed whether all healthy children ages 5-11 needed an extra dose, especially since many children became infected during the giant winter wave of the omicron variant.
But the United States is now experiencing an average of 100,000 new incidents a day for the first time since February. Finally, CDC consultants pointed to the growing evidence that two major vaccines and one booster by older children and adults provide the best protection against the latest coronavirus variants.
Dr. Stanford University, which chairs the CDC’s advisory panel. Grace Lee said: “It should probably have always been a three-dose vaccine.
The reinforcing question is not the hottest vaccination topic: Parents are still looking forward to the chance to vaccinate children under the age of 5 – the only group in the United States that is not yet eligible
Dr Doran Fink of the Food and Drug Administration said the agency was working “as fast as we could” to assess the appeal of vaccine manufacturer Moderna and was waiting for final information from rival Pfizer. The FDA’s advisers are expected to openly discuss the data from one or both companies next month.
It is unknown how much reinforcement will be required for children aged 5-11. Since the vaccinations were launched in November, only about 30% of this age group has received the first two doses of Pfizer.
Dr. Vanderbilt University CDC Adviser. Helen Keipp Talbot said health authorities should do more to get young people hit first.
“It should be a priority,” he said.
Thursday’s decision also means that children aged 5-11 with severely weakened immune systems and three initial injections will qualify for the fourth dose.
Pfizer and its partner BioNTech are currently developing the only COVID-19 vaccine for children of any age in the United States. Children between the ages of 5 and 11 receive up to one-third of the dose given to anyone 12 or older.
In a small study, Pfizer found an amplifier that increases the level of antibodies that fight the virus in these children, including those who can fight the super-infectious omicron variant – the same kind of jump that adults get from an extra stroke.
Vaccines do not always prevent milder infections, and the omicron variant has been able to pass their protection in particular. However, the CDC cited data during an omicron increase that showed that unvaccinated children aged 5-11 were hospitalized twice as often as young people who received the first two doses.
Health authorities say vaccines for all ages still offer strong protection against the worst outcomes of COVID-19, especially after the third dose.
Some particularly high-risk people, including people 50 and older, have been offered a second booster or fourth shot option. And it remains to be seen whether everyone will need additional shots in the fall, presumably redeveloped to offer better protection against new coronavirus variants.
The Associated Press The Department of Health and Science receives support from the Department of Science Education at the Howard Hughes Medical Institute. AP is responsible for all content.
Should children aged 5-11 be given a COVID booster? CDC advisers say yes
Source link Should children aged 5-11 be given a COVID booster? CDC advisers say yes